A retrospective, single centre study analysing 24-month results of intravitreal aflibercept for macular edema due to branch retinal vein occlusion
Latest Information Update: 03 Sep 2021
At a glance
- Drugs Aflibercept (Primary)
- Indications Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- 03 Sep 2021 New trial record